Your account is not claimed yet. You can sign up with ORCID to claim your account.

Michael Jeltsch

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 6

Top Topics

Prostate Cancer

Vascular Endothelial Growth Factor

Top Venues

Science signaling

Scientific reports

University of Helsinki

University of Helsinki (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Helsinki

Finland

Group leader :: Translational Cancer Biology Program

Education History

University of Helsinki

Finland

PHD :: Biochemistry

Publications

Khushbu Rauniyar, Honey Bokharaie, Michael Jeltsch
Expansion and collapse of VEGF diversity in major clades of the animal kingdom. Angiogenesis (2023)
Hannu Koistinen, Jaana Künnapuu, Michael Jeltsch
KLK3 in the Regulation of Angiogenesis-Tumorigenic or Not? International journal of molecular sciences 22 (24) (2021)
Jaana Künnapuu, Honey Bokharaie, Michael Jeltsch
Proteolytic Cleavages in the VEGF Family: Generating Diversity among Angiogenic VEGFs, Essential for the Activation of Lymphangiogenic VEGFs. Biology 10 (2) (2021)
Jaana Künnapuu, Michael Jeltsch
Outside in and brakes off for lymphatic growth. Science signaling 14 (695) (2021)
Sawan Kumar Jha, Khushbu Rauniyar, Ewa Chronowska, Kenny Mattonet, Eunice Wairimu Maina, Hannu Koistinen, Ulf-Håkan Stenman, Kari Alitalo, Michael Jeltsch
KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D. eLife 8 (2019)
Sawan Kumar Jha, Khushbu Rauniyar, Terhi Karpanen, Veli-Matti Leppänen, Pascal Brouillard, Miikka Vikkula, Kari Alitalo, Michael Jeltsch
Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1. Scientific reports 7 (1) (2017)